n-methyl-3,4-methylenedioxyamphetamine has been researched along with dsp 4 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alessrì, MG; Chen, K; Fornai, F; Gesi, M; Giorgi, FS; Shih, JC | 1 |
Casini, A; Ferrucci, M; Fornai, F; Gesi, M; Lenzi, P; Paparelli, A; Pellegrini, A; Ruggieri, S | 1 |
Biezonski, DK; Meyer, JS | 1 |
3 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and dsp 4
Article | Year |
---|---|
Biochemical effects of the monoamine neurotoxins DSP-4 and MDMA in specific brain regions of MAO-B-deficient mice.
Topics: Animals; Benzylamines; Biogenic Monoamines; Brain Chemistry; Chromatography, High Pressure Liquid; Mice; Monoamine Oxidase; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxins | 2001 |
Striatal postsynaptic ultrastructural alterations following methylenedioxymethamphetamine administration.
Topics: Animals; Benzylamines; Biogenic Monoamines; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; N-Methyl-3,4-methylenedioxyamphetamine; Phosphatidylcholines; Synapses | 2002 |
Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
Topics: 5,7-Dihydroxytryptamine; Animals; Area Under Curve; Benzylamines; Brain; Central Nervous System Stimulants; Disease Models, Animal; Female; Gene Expression; Hallucinogens; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Neurotransmitter Uptake Inhibitors; Pregnancy; Protein Binding; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins; Synaptosomes; Time Factors; Vesicular Monoamine Transport Proteins | 2010 |